MICHAEL D. DAKE, MD
Radiology at Pasteur Dr, Palo Alto, CA
License number
California 0101237964
Category
Radiology
Type
Diagnostic Radiology
License number
California C40482
Category
Radiology
Type
Diagnostic Radiology
Address
Address
300 Pasteur Dr, Palo Alto, CA 94305
Phone
(650) 723-4000
Professional information
Dr. Michael D Dake, Stanford CA - MD (Doctor of Medicine)
Specialties:
Pulmonology, Interventional Radiology, Vascular & Interventional Radiology
Address:
Stanford Hospital Cardthrc Sgy
300 Pasteur Dr, Stanford 94305
(650) 724-0831 (Phone)
300 Pasteur Dr, Stanford 94305
(650) 724-0831 (Phone)
Certifications:
Diagnostic Radiology, Internal Medicine, 1981, Interventional Radiology & Vascular Radiology, 2006, Pulmonary Disease, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Stanford Hospital Cardthrc Sgy
300 Pasteur Dr, Stanford 94305
300 Pasteur Dr, Stanford 94305
Education:
Medical School
Baylor University
Graduated: 1978
Baylor
University Of California-San Francisco
Baylor University
Graduated: 1978
Baylor
University Of California-San Francisco
Michael David Dake, Stanford CA
Specialties:
Internal Medicine, Pulmonary Disease, Radiology, Diagnostic Radiology, Vascular & Interventional Radiology
Work:
Stanford University
300 Pasteur Dr, Stanford, CA 94305
300 Pasteur Dr, Stanford, CA 94305
Education:
Baylor College of Medicine (1978) Diagnostic Radiology
Polymerized And Modified Rapamycins And Their Use In Coating Medical Prostheses
US Patent:
2007000, Jan 4, 2007
Filed:
Sep 6, 2006
Appl. No.:
11/517207
Inventors:
Jacob Waugh - Palo Alto CA, US
Mahmood Razavi - Irvine CA, US
Camran Nezhat - Woodside CA, US
Pamela Cifra - Daly City CA, US
Michael Dake - Stanford CA, US
Mahmood Razavi - Irvine CA, US
Camran Nezhat - Woodside CA, US
Pamela Cifra - Daly City CA, US
Michael Dake - Stanford CA, US
International Classification:
A61K 31/4745, A61F 2/06
US Classification:
424426000, 623001110, 514291000
Abstract:
Compositions of matter comprise linked pluralities of mTOR-binding molecules, such as rapamycin. The compositions may be directly polymerized or may comprise rapamycin or other mTOR-binding molecules covalently or non-covalently attached to a backbone molecule. The compositions may be bound to vascular prostheses and other implantable devices in order to inhibit hyperplasia or for other therapeutic purposes.
Branched Stent Graft Device And Deployment
US Patent:
2013021, Aug 15, 2013
Filed:
Aug 13, 2012
Appl. No.:
13/584650
Inventors:
Michael D. Dake - Stanford CA, US
Joshua J. Lovekamp - Phoenix AZ, US
Michael C. Nilson - Flagstaff AZ, US
Edward E. Shaw - Flagstaff AZ, US
Joshua J. Lovekamp - Phoenix AZ, US
Michael C. Nilson - Flagstaff AZ, US
Edward E. Shaw - Flagstaff AZ, US
International Classification:
A61F 2/07, A61F 2/954
US Classification:
623 135
Abstract:
A device for treating disease along a main vessel and at least one branch vessel extending from the main vessel includes a branch member for deployment in the branch vessel, the branch member having a branch lumen; and a main body for deployment in the main vessel. The main body has a generally tubular wall extending generally longitudinally between opposite first and second ends. The wall has an internal surface defining a main lumen and an opposite outer surface. The wall has a recessed portion that is recessed relative to the outer surface of the wall and positioned between the first and second ends of the main body. The main body has an opening formed in the recessed portion of the wall for receiving the branch member therethrough such that the branch lumen is in fluid communication with the main lumen.
Bifurcated Endoluminal Prosthesis
US Patent:
5716365, Feb 10, 1998
Filed:
Jun 5, 1995
Appl. No.:
8/461513
Inventors:
George Goicoechea - Grand Bahama, BS
John Hudson - Clearwater FL
Claude Mialhe - Draguignan, FR
Andrew H. Cragg - Edina MN
Michael D. Dake - Stanford CA
John Hudson - Clearwater FL
Claude Mialhe - Draguignan, FR
Andrew H. Cragg - Edina MN
Michael D. Dake - Stanford CA
Assignee:
Boston Scientific Technologies, Inc. - Maple Grove MN
International Classification:
A61F 1100
US Classification:
606108
Abstract:
An introducer for delivering into the vasculature a straight or bifurcated stent or prosthesis; a method for delivering into the vasculature a straight or bifurcated stent or prosthesis; a method of treating and angeological disease using a bifurcated stent; an endoluminal stent having perpendicular hoop members, each hoop member formed of wire in a sinuous configuration, at least some of juxtaposed apices in neighboring hoops being secured to one another, such stents also forming axially aligned segments in straight stents, and segments of bifurcated stents in particular embodiments. Certain embodiments of such stents also include barbs, fabric covering and radiopaque markers.
Bifurcated Endoluminal Prosthesis
US Patent:
7942919, May 17, 2011
Filed:
Feb 23, 2004
Appl. No.:
10/784378
Inventors:
George Goicoechea - Grand Bahama, BS
Claude Mialhe - Draquignan, FR
John Hudson - Glenfield, GB
Andrew H. Cragg - Edina MN, US
Michael D. Dake - Stanford CA, US
Claude Mialhe - Draquignan, FR
John Hudson - Glenfield, GB
Andrew H. Cragg - Edina MN, US
Michael D. Dake - Stanford CA, US
Assignee:
Scimed Life Systems, Inc. - Maple Grove MN
International Classification:
A61F 2/06, A61F 11/00
US Classification:
623 113, 606108, 606191
Abstract:
The invention comprises:An introducer for delivering into the vasculature a straight or bifurcated stent or prosthesis; a method for delivering into the vasculature a straight or bifurcated stent or prosthesis; a method of treating and angeological disease using a bifurcated stent; an endoluminal stent having perpendicular hoop members, each hoop member formed of wire in a sinuous configuration, at least some of juxtaposed apices in neighboring hoops being secured to one another, such stents also forming axially aligned segments in straight stents, and segments of bifurcated stents in particular embodiments. Certain embodiments of such stents also include barbs, fabric covering and radiopaque markers.
Polymerized And Modified Rapamycins And Their Use In Coating Medical Prostheses
US Patent:
2004007, Apr 15, 2004
Filed:
Jul 2, 2003
Appl. No.:
10/613584
Inventors:
Jacob Waugh - Palo Alto CA, US
Mahmood Razavi - San Carlos CA, US
Camran Nezhat - Woodside CA, US
Pamela Cifra - Daly City CA, US
Michael Dake - Stanford CA, US
Mahmood Razavi - San Carlos CA, US
Camran Nezhat - Woodside CA, US
Pamela Cifra - Daly City CA, US
Michael Dake - Stanford CA, US
International Classification:
A61F002/06, A61K031/4745
US Classification:
514/291000, 623/001460
Abstract:
Compositions of matter comprise linked pluralities of mTOR-binding molecules, such as rapamycin. The compositions may be directly polymerized or may comprise rapamycin or other mTOR-binding molecules covalently or non-covalently attached to a backbone molecule. The compositions may be bound to vascular prostheses and other implantable devices in order to inhibit hyperplasia or for other therapeutic purposes.
Compositions And Methods For Topical Application And Transdermal Delivery Of Botulinum Toxins
US Patent:
2007007, Apr 5, 2007
Filed:
Mar 3, 2006
Appl. No.:
11/367642
Inventors:
Michael Dake - Stanford CA, US
Jacob Waugh - Mountain View CA, US
Jacob Waugh - Mountain View CA, US
Assignee:
Revance Therapeutics, Inc. - Mountain View CA
International Classification:
A61K 9/70, A61K 39/08
US Classification:
424239100, 424449000
Abstract:
Improved formulations for transdermal delivery of botulinum toxin are disclosed. The formulations include, for example, botulinum toxin non-covalently associated with a positively charged backbone having branching or efficiency groups. The formulations also include a partitioning agent, oligo-bridge, or polyanion bridge, and may optionally contain a viscosity modifying agent. The formulations are designed for topical application onto the skin of a patient and may be used to treat wrinkles, hyperhidrosis, and other health-related problems. Kits for administration are also described.
Endoluminal Prosthesis And System For Joining
US Patent:
6117167, Sep 12, 2000
Filed:
Feb 9, 1998
Appl. No.:
9/020749
Inventors:
George Goicoechea - Freeport, BS
John Hudson - Glenfield, GB
Claude Mialhe - Draguignan, FR
Andrew H. Cragg - Edina MN
Michael D. Dake - Stanford CA
John Hudson - Glenfield, GB
Claude Mialhe - Draguignan, FR
Andrew H. Cragg - Edina MN
Michael D. Dake - Stanford CA
Assignee:
Boston Scientific Technology, Inc. - Maple Grove MN
International Classification:
A61F 200
US Classification:
623 116
Abstract:
A stent joining means is provided for joining a first endoluminal stent to a second endoluminal stent to define a continuous lumen through the first and second endoluminal stents. The stent joining means includes two transversely spaced female portions on the first endoluminal stent. The stent joining means also includes a male engaging portion of the second endoluminal stent. The male engaging portion is configured to be entered into one of the female portions in a radially compressed state and thereafter expanded in the female portion such that an outer surface of the male engaging portion and an inner surface of the female portion are interengaged to resist longitudinal movement to prevent separation of the first and second endoluminal stents in service.
Aortic Dissection Septal Cutting Tool
US Patent:
2014001, Jan 9, 2014
Filed:
Sep 10, 2013
Appl. No.:
14/023109
Inventors:
Edward H. Cully - Flagstaff AZ, US
Michael D. Dake - Stanford CA, US
Joel M. Greene - Flagstaff AZ, US
Joshua J. Lovekamp - Flagstaff AZ, US
Michael C. Nilson - Flagstaff AZ, US
Himanshu J. Patel - Ann Arbor MI, US
David M. Williams - Ann Arbor MI, US
William P. Witort - Berkeley CA, US
Michael D. Dake - Stanford CA, US
Joel M. Greene - Flagstaff AZ, US
Joshua J. Lovekamp - Flagstaff AZ, US
Michael C. Nilson - Flagstaff AZ, US
Himanshu J. Patel - Ann Arbor MI, US
David M. Williams - Ann Arbor MI, US
William P. Witort - Berkeley CA, US
Assignee:
W. L. Gore & Associates, Inc. - Newark DE
International Classification:
A61B 18/14, A61B 18/18
US Classification:
606 33, 606159, 606 46
Abstract:
The present invention relates to methods of using medical cutting tools for treating aortic septal dissections.